Specialties
Board Certification
|
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Geriatric Medicine)
National Board of Medical Examiners
|
Patient Rating
Patients describe Dr. Hueftle as thorough, attentive, and knowledgeable, noting she reviews medical history carefully and asks thoughtful questions. Many say they feel heard and supported, with clear explanations of diagnoses and treatment plans and inclusion in decision-making. Reviewers also praise prompt follow-up and timely lab result communication, as well as compassionate, helpful clinic staff. Several comments highlight her holistic approach to care and strong rapport with patients.
Generated via Patient Reviews
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Geriatrics
|
| Board Certification |
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Geriatric Medicine)
National Board of Medical Examiners
|
Education history
| Fellowship | Geriatric Medicine - University of Utah School of Medicine | Fellow |
|---|---|---|
| Residency | Internal Medicine - University of Utah School of Medicine | Resident |
| Internship | Internal Medicine - University of Utah School of Medicine | Intern |
| Professional Medical | Medicine - Creighton University School of Medicine | M.D. |
| Undergraduate | Cell Biology and Neuroscience, Biomedical Sciences option - Montana State University | B.S. |
Selected Publications
Journal Article
- Werner T, Ray A, Lamb J, Van Brocklin M, Hueftle K, Cohen A, Beck A, Buys S, Dyess D, Butler T, Dumlao T, Khong H (November 2017). Neoadjuvant Chemotherapy with Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel), Adriamycin and Cyclophosphamide (NAC) in Patients with Stage II-III Breast Cancer. Clin Breast Cancer, 17(7), 503-509.